Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PPAR Res
Main Authors: Choung, Sorim, Joung, Kyong Hye, You, Bo Ram, Park, Sang Ki, Kim, Hyun Jin, Ku, Bon Jeong
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020545/
https://ncbi.nlm.nih.gov/pubmed/30008738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4292509
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki